These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 34122308)

  • 1. The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
    MacMahon Copas AN; McComish SF; Fletcher JM; Caldwell MA
    Front Neurol; 2021; 12():666737. PubMed ID: 34122308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation in Parkinson's disease and its potential as therapeutic target.
    Wang Q; Liu Y; Zhou J
    Transl Neurodegener; 2015; 4():19. PubMed ID: 26464797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson's Disease.
    Chen K; Wang H; Ilyas I; Mahmood A; Hou L
    Brain Sci; 2023 Apr; 13(4):. PubMed ID: 37190599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia Mediated Neuroinflammation in Parkinson's Disease.
    Isik S; Yeman Kiyak B; Akbayir R; Seyhali R; Arpaci T
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review).
    Zhang N; Yan Z; Xin H; Shao S; Xue S; Cespuglio R; Wang S
    Exp Ther Med; 2024 Jan; 27(1):23. PubMed ID: 38125364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodromal non-motor symptoms of Parkinson's disease.
    Pellicano C; Benincasa D; Pisani V; Buttarelli FR; Giovannelli M; Pontieri FE
    Neuropsychiatr Dis Treat; 2007 Feb; 3(1):145-52. PubMed ID: 19300544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF, Mechanism of Action, Role in Parkinson's Disease, and Therapeutics.
    Liu Y; Deng J; Liu Y; Li W; Nie X
    Front Pharmacol; 2021; 12():675725. PubMed ID: 34234672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review.
    Nies YH; Mohamad Najib NH; Lim WL; Kamaruzzaman MA; Yahaya MF; Teoh SL
    Front Neurosci; 2021; 15():660379. PubMed ID: 33994934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of α-synuclein on gliosis and IL-1α, TNFα, IFNγ, TGFβ expression in murine brain.
    Sznejder-Pachołek A; Joniec-Maciejak I; Wawer A; Ciesielska A; Mirowska-Guzel D
    Pharmacol Rep; 2017 Apr; 69(2):242-251. PubMed ID: 28126640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic strategy for Parkinson's disease: targeting zinc-binding protein in astrocytes].
    Miyazaki I; Asanuma M
    Nihon Yakurigaku Zasshi; 2021; 156(2):76-80. PubMed ID: 33642534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
    Kuter K; Olech Ł; Głowacka U
    Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glymphatic System Dysfunction and Sleep Disturbance May Contribute to the Pathogenesis and Progression of Parkinson's Disease.
    Scott-Massey A; Boag MK; Magnier A; Bispo DPCF; Khoo TK; Pountney DL
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease.
    Deng I; Corrigan F; Zhai G; Zhou XF; Bobrovskaya L
    Brain Behav Immun Health; 2020 Apr; 4():100060. PubMed ID: 34589845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.